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Objectives
Figure 1

•

To describe effectiveness of
repeat dexamethasone
treatment for bronchopulmonary
dysplasia (BPD) and to evaluate
potential detrimental effects on
growth and neurodevelopment.

•

•

•

10-year single-center
observational study
Infants <30 weeks’ gestational
age at birth treated with 1 or 2
courses of systemic
dexamethasone for BPD
Effectiveness was defined as
step-down in mode of respiratory
support from baseline by end of
treatment.
Adverse effects on growth zscores and Bayley-III
neurodevelopment scores were
analyzed and compared to a
cohort of untreated controls.

34 remain
intubated

Figure 2

•

63 (48%)
failed to
extubate

69 (52%)
extubated
to NIV

Methods
•

132 intubated infants
treated with 1 st PNS
course

29 eventually
extubated to NIV

34 intubated infants
treated with 2 nd PNS
course

18 infants on NIV
treated with 2 nd
PNS course

12 (35%)
extubated
to NIV

8 (44%)
weaned to NC

11 eventually
weaned to NC

Compared to untreated controls, repeat
dexamethasone treatment was associated
with lower Bayley cognitive scores (76.7 vs
86.4) and motor scores (71.7 vs 84.6) but
this association was no longer significant
after adjusting for confounders.

Conclusions
•

A second course of dexamethasone for BPD
was less effective in weaning respiratory
support compared to the initial course but
was not associated with detrimental effects
on growth or neurodevelopment.

